Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Iveric Bio’s Izervay for Geographic Atrophy Approved by FDA
Parent company Astellas Pharma announced that Iveric Bio has received FDA approval for Izervay (avacincaptad pegol intravitreal solution) to treat geographic atrophy (GA) secondary to age-related macular degeneration (AMD). As a new complement C5 inhibitor, Izervay stands out as the sole…
Best Treatment for Uveitic Macular Edema Identified
Repeat corticosteroid injections were found to be more effective in improving vision for individuals with persistent or recurrent uveitis-related macular edema compared to methotrexate or ranibizumab intravitreal injections, according to a recent clinical trial. The corticosteroid treatment exhibited superior results…
Study Unveils the Dynamic Architecture of the Human Eye
The retinal pigment epithelium (RPE) and choroid, located behind the human retina, play crucial roles in vision, encompassing functions such as light absorption and providing oxygenated blood to photoreceptor cells. However, our current understanding of gene expressions within these cells…
Aegis and Northwell Launch AI Company Optain
Ascertain, a joint venture between Aegis Ventures and Northwell Holdings, has raised $12 million in seed funding to launch Optain, an AI company that utilizes retinal imaging for early disease detection and prevention. Optain’s AI technology analyzes data from a…
Tenpoint Therapeutics Launches with $70M Financing
Tenpoint Therapeutics, a biotechnology company focused on vision-restoring engineered cell-based therapeutics and in vivo reprogramming for degenerative ocular diseases, has announced its launch with a $70 million Series A financing. The funding will be used to develop the company’s regenerative…
2023 Recap: Top 10 Contact Lenses and Technologies
In the ever-evolving landscape of ophthalmology, 2023 has proven to be a year of groundbreaking advancements in contact lens technology. From lenses that adapt to UV and temperature changes to intelligent lenses capable of diagnosing and treating glaucoma, the top…
Glaucoma Patients Miss Regular Eye Doctor Visits
In the August issue of Ophthalmology Epidemiology, a recently published study unveils a concerning trend among glaucoma patients. It was discovered that one-third of these patients ceased to visit their eye doctors for regular check-ups over a 10-year period. Conducted…
Glaucomatous Optic Neuropathy & Latest Treatments
Glaucomatous optic neuropathy is characterized by progressive loss of retinal ganglion cells (RGCs) and their axons and leads to measureable structural and functional damage to the optic nerve, visual impairment, and blindness. The primary site of injury is thought to be…
Pros and Cons of Laser Surgery for Glaucoma Patients
Glaucoma is a complex eye condition characterized by increased intraocular pressure, which can lead to damage to the optic nerve and vision loss if left untreated. This group of eye disorders often develops without noticeable symptoms in its early stages,…
Anterior Uveitis: Causes, Symptoms and Treatment
Picture this: You’re an astronaut on a space mission, and you’ve just stepped out of your spacecraft onto the surface of a mysterious new planet. Your eyesight is crucial to your survival in this alien environment, as you must rely…